- You can view the full Johnson & Johnson Ratings Report.
- Use our drugs section to find industry-relevant news.
- Or find some new ideas from our top rated stocks lists.
- Find other investment ideas from our top rated ETFs lists.
A KeyBanc Capital Markets analyst increases his price target on the stock to $221 from $199.
Stock losses accelerate on Thursday as Deutsche Bank and Wells Fargo drag on the financials sector.
The little-guy investing group the Bogleheads is back.
As consumer confidence and health care spending soar, Johnson & Johnson is becoming one of the best total return packages available.